In The Joe Rogan Experience #2440 with Matt Damon and Ben Affleck, Rogan touches on mushrooms, psychedelics, and especially ibogaine as game-changers for PTSD, Traumatic Brain Injury, mental health and addiction. It’s captivating stuff—Rogan’s enthusiasm makes you want to book a flight to a clinic. Let’s unpack this. Is ibogaine really legal in Texas? Does one dose of ibogaine zap addiction for 80% of people? And are psychedelics a silver bullet for brain injuries and PTSD in fighters or vets?

Spoiler: The reality is promising, but way more nuanced than the podcast lets on. Buckle up for a balanced breakdown that’ll arm you with the real deal.

To give credit where due, JRE #2251 with Rick Perry & W. Bryan Hubbard is the episode where Ibogaine as a subject is introduced and unpacked in a very well rounded manner. And I think it is a vital episode for anyone who might need to be involved with ibogaine.

The Episode Buzz: Rogan’s Take on Psychedelics and Ibogaine

In #2440, Rogan chats with Damon and Affleck about ibogaine’s potential, drawing from his convos with folks like former Texas Governor Rick Perry. He paints ibogaine as a powerhouse for treating addiction, PTSD, and even traumatic brain injuries (TBIs)—common in combat sports pros and military vets. Mushrooms and other psychedelics get nods for brain health benefits. The tone? Highly optimistic, almost evangelical. Rogan highlights success stories, like vets ditching opioids after one session, but skims over risks, specifics on dosing, or the need for pros in the room. It’s engaging as hell—perfect for viral clips—but leaves out key caveats that could mislead listeners chasing quick fixes.

Claim 1: Ibogaine Is Legal in Texas? Not Quite

Rogan mentions ibogaine’s push in Texas, implying it’s accessible or on the verge of mainstream. He references Perry’s advocacy and state initiatives, making it sound like Texas is has authorized ibogaine for use. But let’s clarify: Ibogaine is not legal for general use in Texas or anywhere in the U.S. It’s a Schedule I substance federally—meaning no accepted medical use and high abuse potential, per the DEA. Possession can land you felony charges in Texas.

That said, Texas is funding research. In June 2025, Governor Greg Abbott signed Senate Bill 2308, allocating up to $50 million for FDA-approved clinical trials on ibogaine for opioid addiction, depression, and PTSD—especially for vets. UTHealth Houston leads this, partnering with hospitals and drug devs. Arizona followed suit with similar funding. So, Rogan’s excitement tracks with progress, but it’s research-only for now—not a green light for DIY trips. Many seek treatment in Mexico, where it’s unregulated, but that’s risky: U.S. border crossings could mean arrests, and clinics vary wildly in safety. The podcast’s casual tone glosses over this, potentially giving false hope or encouraging illegal moves.

Claim 2: One Dose of Ibogaine Cures Addiction in 80% of Cases? Pump the Brakes

Rogan cites an 80% success rate for ibogaine wiping out addiction after just one dose—drawing from anecdotal vet stories and Perry’s push. Sounds revolutionary, right? But science says it’s more about short-term wins than lifelong cures.

Studies show ibogaine excels at reducing physical withdrawal symptoms in 80% of users—think nausea, cravings, and shakes vanishing fast. A 2017 survey of 88 opioid addicts found 80% had drastically reduced withdrawals, and 50% curbed cravings for weeks to months. But long-term sobriety? That’s trickier. Only 30% stayed opioid-free forever, with relapses hitting 70% overall—though many reduced use or eventually quit. A 12-month follow-up on 14 users saw sustained reductions, but one death during treatment highlights risks.

The 80% figure often gets twisted—it’s for acute relief, not “complete removal” of addiction. Ibogaine resets brain receptors (like dopamine and serotonin), but without therapy or support, old habits creep back. Rogan’s omission of relapse rates and the need for aftercare (like rehab) makes the claim feel overhyped. On X, users echo this buzz, with threads praising ibogaine as a “cure” but ignoring fatalities from heart issues.

Claim 3: Psychedelics as a Cure-All for Brain Injuries and PTSD? Promising, But Not Without Warnings

Rogan generalizes psychedelics (mushrooms like psilocybin, ibogaine) as brain-boosters for Traumatic Brain Injury (TBI) and PTSD in fighters and vets—citing neuron growth and “profound spiritual experiences.” He’s spot-on about potential: A Stanford study on 30 special ops vets found ibogaine (with magnesium for heart safety) slashed PTSD by 88%, depression/anxiety by over 80%, and TBI symptoms significantly—one month post-dose. Psilocybin stimulates neuron growth via 5-HT2A receptors, aiding depression and PTSD.

But here’s the critique: Rogan skips specifics. Not all psychedelics are equal—psilocybin for depression, MDMA for PTSD, ibogaine for addiction/TBI. Doses matter: 10-30mg psilocybin orally, but microdosing shows little effect vs. macro-doses. Supervision is crucial—VA trials emphasize medical monitoring to avoid risks like anxiety, nausea, or worse (ibogaine’s cardiac threats). Omitting these? It’s like recommending skydiving without a parachute.

The Bigger Picture: Hype vs. Hope in Psychedelic Therapy

Rogan’s style—raw, passionate—fuels vital conversations, like Perry’s vet advocacy. But the episode’s tone risks oversimplifying: No deep dive on risks (e.g., ibogaine fatalities), diversity in psychedelics, or therapy integration. It’s meaningful for spotlighting alternatives amid the opioid crisis, but viral without caveats could harm. Bottom line? Psychedelics show real promise—rewiring brains, cutting symptoms—but they’re tools, not miracles. Consult pros, join trials (VA’s exploring psilocybin for vets), and blend with therapy for best results.

Sources and editional readings

JRE#2251: https://youtu.be/pcCKDDa3MzY?si=ziJUFmxGPB9WPbeF

Ibogaine Legal Status in Texas (Research Funding, Not Legal for Use)

•  Governor Abbott Signs Ibogaine Treatment Research Law (Texas Gov. site, Jun 2025) – Senate Bill 2308 signed for FDA-approved trials.
https://gov.texas.gov/news/post/governor-abbott-signs-ibogaine-treatment-research-law-at-texas-capitol

•  Texas Senate Bill 2308 Text (LegiScan/Enrolled version) – Establishes consortium for clinical trials on ibogaine for opioid use disorder, PTSD, etc.
https://legiscan.com/TX/text/SB2308/id/3256888

•  HHSC Ibogaine Clinical Trials Page – UTHealth Houston leading, research-only focus.
https://www.hhs.texas.gov/services/mental-health-substance-use/mental-health-substance-use-resources/ibogaine-clinical-trials

•  Texas Tribune article (Jun 2025) – $50M funding for trials, ibogaine remains Schedule I federally.
https://www.texastribune.org/2025/06/11/texas-psychedelics-ibogaine-treatment-addiction-rick-perry-funding

Ibogaine Addiction Treatment Claims (80% Figure, One Dose, Relapse Rates)

•  Subjective effectiveness of ibogaine treatment… (PubMed Central, 2017 study on 88 opioid users) – 80% reduced/elimated withdrawal; 50% reduced cravings; long-term abstinence ~30%.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6157925

•  Ibogaine treatment outcomes… 12-month follow-up (Taylor & Francis, 2017) – Significant reductions but relapses common; one death noted.
https://www.tandfonline.com/doi/full/10.1080/00952990.2017.1310218

•  Various reviews/clinics (e.g., Ambio Life Sciences, Root Healing) – 80% acute withdrawal relief cited often; long-term success 30-50%; relapse rates high without support.
https://ambio.life/blog/success-rates-in-ibogaine-treatment ; https://www.roothealing.com/post/success-rate-of-ibogaine-iboga

Ibogaine/Psychedelics for PTSD, TBI in Veterans (Stanford Study, etc.)

•  Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Nature Medicine, 2024) – Stanford MISTIC protocol; 88% PTSD reduction, major improvements in depression/anxiety/TBI symptoms in 30 vets.
https://www.nature.com/articles/s41591-023-02705-w

•  Stanford Medicine News (Jan 2024) – Summary of ibogaine + magnesium safety/efficacy in vets.
https://med.stanford.edu/news/all-news/2024/01/ibogaine-ptsd.html

•  ClinicalTrials.gov: NCT04313712 – Pre-post evaluation of ibogaine-magnesium in veterans with blast exposure/TBI.
https://clinicaltrials.gov/study/NCT04313712

Risks & Fatalities (Cardiac Issues, QT Prolongation)

•  Ibogaine-associated cardiac arrest and death: case report and review (PMC, multiple cases) – Cardiac complications in fatalities.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4837967

•  Fatalities after taking ibogaine… autonomic dysfunction/sudden cardiac death (ScienceDirect/PubMed, 2006 hypothesis) – Links to arrhythmias.
https://pubmed.ncbi.nlm.nih.gov/16698188

•  Multiple Episodes of Cardiac Arrest Induced by Treatment With Ibogaine (Cureus, 2024 case) – Long QT and arrests even at lower doses.
https://www.cureus.com/articles/264670-multiple-episodes-of-cardiac-arrest-induced-by-treatment-with-ibogaine-a-case-report

•  General reviews (e.g., Corkery 2018, Alper et al.) – 19-33 reported deaths worldwide, many cardiac-related in unregulated settings.